METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE

Generic: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE

Sun Pharmaceutical IndustriesManufacturer
ORALRoute
METOPROLOL TARTRATEActive Substance
2012-01-19Original Approval

METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE is FDA application ANDA090654, sponsored by SUN PHARM INDS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2021-03-15
Metoprolol Tartrate and Hydrochlorothiazide Tablets, USP 50 mg/25 mg 100 Tablets Rx only NDC 62332-115-31 Manufactured f

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Top Reported Reactions

1
NAUSEA
15 reports
2
FATIGUE
13 reports
3
DEATH
11 reports
4
DYSPNOEA
11 reports
5
RENAL FAILURE ACUTE
11 reports
6
DIARRHOEA
10 reports
7
ANAEMIA
9 reports
8
ASTHENIA
9 reports
9
DIZZINESS
9 reports
10
DRUG INTERACTION
8 reports